Welcome to our dedicated page for Cerence SEC filings (Ticker: CRNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cerence Inc. SEC filings document formal disclosures for a public software company focused on conversational AI-powered user experiences. Recent 8-K filings include earnings releases and investor presentations with GAAP and non-GAAP financial measures, revenue and cash-flow disclosures, and commentary on software licensing, connected services and customer-program activity.
The filings also record shareholder meeting results, board elections, advisory compensation votes, auditor ratification, restructuring-related charges, executive compensation arrangements, and material intellectual-property matters, including patent litigation resolution and license agreements. These records frame Cerence's governance, operating costs, capital allocation and technology-rights disclosures.
Harris Marion reported acquisition or exercise transactions in this Form 4 filing.
Cerence Inc. director Marion Harris reported an equity award of 12,968 shares of common stock at $0.01 per share on February 12, 2026. This grant increased Harris’s directly held stake to 27,178 shares.
The award is structured as restricted stock units that will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal year annual general meeting.
Cerence Inc. reported strong top-line growth for the three months ended December 31, 2025, with total revenue rising to $115.1 million from $50.9 million, driven largely by a $49.5 million one-time IP license payment from a cross-license agreement with Samsung.
License revenue jumped to $87.8 million, while connected services and professional services contributed $14.5 million and $12.8 million, respectively. Operating results improved to $29.3 million income from operations versus a prior-year loss, despite $7.8 million in restructuring and other costs and about $20.7 million of legal fees tied to the Samsung matter.
After a $35.3 million income tax provision, Cerence posted a net loss of $5.2 million, narrower than the $24.3 million loss a year earlier. Cash flow from operations strengthened to $37.9 million, cash and cash equivalents were $92.1 million, and long-term debt declined to $171.9 million following repurchases of 2028 convertible notes.
Cerence Inc. furnished an update on its recent performance by announcing financial results for the fiscal quarter ended December 31, 2025. The company issued a press release and an accompanying investor presentation on February 4, 2026, both of which include detailed financial data and non-GAAP measures.
The materials, filed as Exhibits 99.1 and 99.2, also provide reconciliations between GAAP and non-GAAP figures and explain why these non-GAAP metrics are used. This information is furnished under a current report, meaning it is not treated as being formally filed for certain liability purposes.
Cerence Inc. chief executive officer Brian M. Krzanich reported an equity award of 263,338 shares of common stock on January 9, 2026. The filing shows these shares at a reference price of $12.35 per share and indicates he beneficially owned 1,722,091 shares of Cerence common stock after this grant, held directly.
According to a footnote, the award is structured as restricted stock units under a Restricted Stock Unit Agreement. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of October 1, 2026, October 1, 2027 and October 1, 2028, tying the compensation to continued service over that period.
Cerence Inc. reported that EVP and Chief Revenue Officer Christian Mentz received an award of 131,694 shares of common stock on January 9, 2026 at a price of $12.35 per share. The award is in the form of restricted stock units that vest in three equal parts on October 1, 2026, 2027, and 2028 under a Restricted Stock Unit Agreement. Following this grant, Mentz beneficially owns 293,474 shares of Cerence common stock in direct ownership.
Cerence Inc. executive Nils Schanz, EVP Product & Technology, reported receiving a grant of 87,796 shares of common stock on January 9, 2026. The filing describes this as a grant of restricted stock units under a Restricted Stock Unit Agreement at a reported price of $12.35 per share. According to the footnote, the shares vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Schanz beneficially owns 342,682 shares of Cerence common stock, held directly.
Cerence Inc. executive Jennifer Salinas, EVP Chief Admin Officer, received a sizable equity award. On January 9, 2026, she was granted 131,694 shares of common stock at a price of $12.35 per share, reported as an acquisition of non-derivative securities.
The grant is described as restricted stock units under a Restricted Stock Unit Agreement, with the shares vesting in three equal installments on October 1, 2026, October 1, 2027, and October 1, 2028. Following this grant, Salinas beneficially owns 720,027 shares of Cerence common stock directly.
Cerence Inc. CFO Antonio Rodriquez reported an equity award on a Form 4. On January 9, 2026, he was granted 131,694 shares of Common Stock, reflecting restricted stock units with a reported value of $12.35 per share.
The footnote explains this is a grant of Restricted Stock Units under a Restricted Stock Unit Agreement. The RSUs vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Rodriquez beneficially owned 575,246 shares of Cerence common stock, held directly.
Cerence Inc. (CRNC) reported an equity award to its Chief Executive Officer and director on a Form 4. On 11/21/2025, the executive acquired 552,766 shares of common stock at a price of $10.35 per share, classified as an acquisition transaction. Following this grant, the executive beneficially owns 1,458,753 shares of Cerence common stock in direct ownership.
The filing notes that this grant represents performance stock units (PSUs) achieved under the company’s FY25 plan, which are scheduled to vest in November 2027. This reflects a performance-based equity incentive aligning the CEO’s compensation with Cerence’s future results over the multi‑year performance period.
Cerence Inc. (CRNC) executive vice president and chief administrative officer reported acquiring 242,044 shares of common stock on 11/21/2025 at $10.35 per share. These shares reflect achieved performance stock units (PSUs) under the company’s fiscal 2025 plan that are scheduled to vest in November 2027.
Following this transaction, the officer beneficially owns 588,333 shares of Cerence common stock in direct ownership. The filing is made on Form 4 by a single reporting person and documents an equity-based compensation event rather than an open-market purchase.